← FDA Drug Approvals (Drugs@FDA)
BOSUTINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDUSTRIES · Approved 2023-08-25
Drug application
- FDA Application #
ANDA209577- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BOSUTINIB
- Generic name
- Bosutinib Monohydrate
- Active ingredients
- BOSUTINIB MONOHYDRATE
- Dosage form
- TABLET
- Route
- FILM COATED
- Marketing status
- None (Tentative Approval)
- Sponsor
- SUN PHARM INDUSTRIES
- First approval
- 2023-08-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown